Notice of Q4 and year-end results

GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016

London, UK, 30 Nov 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 5 December, 2016 its fourth quarter and year-end financial results for the period ending 30 September, 2016. GW will also host a conference call the same day at 8:00 a.m. EST (1:00 p.m. GMT). Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on

... read more at: http://www.lse.co.uk/regulatory-news-article.asp?ArticleCode=0ula5p31&ArticleHeadline=Notice_of_Q4_and_yearend_results

by